Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lila Zabaglo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cytometry. Part B, Clinical Cytometry|October 29, 2003
Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistryLila Zabaglo, Michael G Ormerod, Mitch Dowsett
The Journal of Pathology. Clinical Research|October 17, 2025
Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797)Suzanne Parry, Lila Zabaglo, Abeer M Shaaban, et al.
Histopathology|February 16, 2021
A simple digital image analysis system for automated Ki67 assessment in primary breast cancerAnastasia Alataki, Lila Zabaglo, Holly Tovey, et al.
Breast Cancer Research : BCR|December 25, 2009
Who would have thought a single Ki67 measurement would predict long-term outcome?Mitch Dowsett, Roger A'Hern, Janine Salter, et al.
Journal of Clinical Pathology|August 19, 2015
Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity studyAndrew Dodson, Lila Zabaglo, Belinda Yeo, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 25, 2003
Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cellsLila Zabaglo, Michael G Ormerod, Marina Parton, et al.
Journal of Clinical Pathology|July 31, 2010
Comparative validation of the SP6 antibody to Ki67 in breast cancerLila Zabaglo, Janine Salter, Helen Anderson, et al.
Journal of the National Cancer Institute|September 14, 2013
Factors predicting late recurrence for estrogen receptor-positive breast cancerIvana Sestak, Mitch Dowsett, Lila Zabaglo, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Steroids|April 8, 2011
Predictive algorithms for adjuvant therapy: TransATACMitch Dowsett, Janine Salter, Lila Zabaglo, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cytometry. Part B, Clinical Cytometry|October 29, 2003
Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistryLila Zabaglo, Michael G Ormerod, Mitch Dowsett
The Journal of Pathology. Clinical Research|October 17, 2025
Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797)Suzanne Parry, Lila Zabaglo, Abeer M Shaaban, et al.
Histopathology|February 16, 2021
A simple digital image analysis system for automated Ki67 assessment in primary breast cancerAnastasia Alataki, Lila Zabaglo, Holly Tovey, et al.
Breast Cancer Research : BCR|December 25, 2009
Who would have thought a single Ki67 measurement would predict long-term outcome?Mitch Dowsett, Roger A'Hern, Janine Salter, et al.
Journal of Clinical Pathology|August 19, 2015
Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity studyAndrew Dodson, Lila Zabaglo, Belinda Yeo, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 25, 2003
Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cellsLila Zabaglo, Michael G Ormerod, Marina Parton, et al.
Journal of Clinical Pathology|July 31, 2010
Comparative validation of the SP6 antibody to Ki67 in breast cancerLila Zabaglo, Janine Salter, Helen Anderson, et al.
Journal of the National Cancer Institute|September 14, 2013
Factors predicting late recurrence for estrogen receptor-positive breast cancerIvana Sestak, Mitch Dowsett, Lila Zabaglo, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Steroids|April 8, 2011
Predictive algorithms for adjuvant therapy: TransATACMitch Dowsett, Janine Salter, Lila Zabaglo, et al.
Pageof 3